Abstract
Management of COVID-19 infection is evolving with the understanding of the disease. There is well-established literature pointing towards the increased coagulation risk associated with COVID-19. This study compares the relative coagulation risk between the COVID-19 and influenza patients. This study aims to analyze the risk of venous thrombosis and arterial thrombosis because of COVID-19 as compared with influenza.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
